WO1999026901A1 - Method of designing chemical substances - Google Patents
Method of designing chemical substances Download PDFInfo
- Publication number
- WO1999026901A1 WO1999026901A1 PCT/GB1998/003017 GB9803017W WO9926901A1 WO 1999026901 A1 WO1999026901 A1 WO 1999026901A1 GB 9803017 W GB9803017 W GB 9803017W WO 9926901 A1 WO9926901 A1 WO 9926901A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- candidates
- array
- sites
- variation
- paired
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
- G16C20/64—Screening of libraries
Definitions
- This invention relates to a method of designing chemical substances, and particularly, but not exclusively, to such a method for use in Combinatorial Chemistry applications.
- Combinatorial Chemistry is the synthesis of large numbers of chemical compounds from smaller numbers of building blocks by assembling them in all combinations; the approach has been increasingly used in the last few years as an aid to chemists searching for (or designing) a pharmaceutical compound with desired biological properties. It is, however, of more general applicability.
- a set of m candidates (monomers) are selected for each substituent group and an m x m x m array is synthesized of all possible combinations of substituent groups. If m is 10 then the final array contains 1000 compounds. This will be referred to as the 'All-Combinations' approach. For this approach the number of monomers (m) at each site need not be identical. With m s l at one site. m s2 at the second site, and m s3 at the third site, then an m s l x m s2 x m s3 array is created. Appendix 1 provides a definition of the symbols used.
- the alternative ('Cherry-Picking') approach involves creating a virtual array of n by n by n (where n > m) compounds and using commercially available molecular modelling software to select a diverse subset of m 3 compounds to synthesise. This approach allows n to be greater than m for the same final number of compounds and so potentially increases the molecular diversity that is present in the final array.
- a method of designing a chemical substance having a desired physical property comprising: (a) selecting r (r >3) sets of candidate elements , C ... C r; ; (b) generating an all-combinations array of possible substances, each element of the array being representative of a different substance having one element chosen from each of the sets Cj, ...C r ;
- the method of the present invention has a number of advantages. For example. it provides an optimum selection of substances with a larger virtual array, thus minimising the possibility of "missing" desirable substances within that larger virtual array.
- the sub-array is defined by a Latin Square or a set of orthogonal Latin Squares.
- the Latin Square is a sub-array optimised such that each element within a given set of candidate elements is paired exactly once with each element within each other set of candidates.
- the sub-array may be defined by two Latin Squares.
- Each of the sets C ⁇ ... C r may have the same number, m, of candidates.
- the candidate elements in the sets may further, or alternatively, be mutually exclusive.
- the chemical substance to be designed may be an admixture of the candidate elements, such as, for example, a paint.
- the chemical substance may be a molecule.
- the desired physical property may be biological activity.
- the molecule will preferably be a pharmaceutical compound.
- the contributions of the various candidates elements in a pharmaceutical compound are not synergistic or antagonistic. It is thus possible to generate a mathematical algorithm that permits prediction of the overall biological activity of those compounds within the complete array that have not yet been synthesized.
- the molecule preferably comprises a fixed scaffold having r sites of variation, each of the sets C ⁇ ... C r being representative of candidate elements for an individual site.
- the scaffold may, for example, be a benzene ring, or a plurality of aromatic or heterocylic rings.
- the scaffold may arise from reaction of the sets C ⁇ ... C r or may constitute a starting framework to which the sets C_ ... C r are attached.
- Compounds created by linear addition of monomers (Cj + C 2 ...+ C r ) do not contain a core scaffold as such but are still relevant to the design.
- the sub-array is defined by a Graeco-Latin Square consisting of two orthogonal Latin Squares.
- a sub-array permits r to be 4 whilst still providing an optimal sub-array such that each element within a given set of candidate elements is paired exactly once with each element within each other set of candidates.
- An additional orthogonal Latin Square is added for each increment of r.
- the method may further comprise calculating from the measured physical properties of the synthesised substances property' contribution values representative of the respective contribution to the physical property of each of the individual elements. Additionally, it may include predicting the characteristics of the possible substances which have not been synthesised in dependence upon the property contribution values.
- the property contribution value for a given candidate element is calculated by summing the measured physical properties of each synthesised substance containing that element, and subtracting the overall mean.
- the predicted characteristics may be calculated by minimising an error function which characterises an error between the actual and predicted measurements of the property' value for those substances that have been synthesised or calculated by summing the property' contribution values for the relevant substance.
- Information is obtained from the screening process about active and inactive compounds in a structured way enabling trends between structure and activity to be modelled and other compounds with unexpected activity or inactivity levels to be identified and f rther studied.
- One preferred method of selecting the r sets of candidate elements is to use a cluster analysis.
- the method might include selecting a candidate element having a high property contribution, identifying from the cluster analysis a so far unused element which would be expected to have similar properties, adding the said so far unused element to one of the r sets of candidate elements C ⁇ ,...C r , either in addition to the existing elements or in substitution for one of them, and repeating steps (b) to (g) of the method according to the first aspect of the present invention one or more times.
- a method of designing a chemical compound including:
- a method of designing a chemical compound including:
- the method according to these aspects of the present invention allows an increase in m (the number of possible variants on a particular site in a compound) without increasing the number of compounds that need actually to be generated. This is done by generating a structured sub-array in the full n r array which maximises the chances of locating materials of interest from that full array. The method therefore provides an advantage over the all- combinations approach outlined above where the time to produce the whole n r array rapidly becomes prohibitive.
- the combination of compound generation and testing provides an iterative technique to pinpoint compounds within the overall array (N) to be synthesized which may be of interest, but which were not part of the original sub-array generated.
- Fig. 1 shows a schematic representation of a chemical compound comprising a core scaffold and three sites of variation
- Figs. 2a, 2b and 2c show three different chemical scaffolds with similar substituent group positions and orientations;
- Fig. 3 shows an example of a hetero ring scaffold with 2 substituent sites where variation can occur, formed by the reaction of two monomers.
- Figs. 4a, 4b and 4c show three chemical scaffolds with different numbers of possible substituent sites
- Fig. 5 shows an example of a linear addition of monomers giving rise to a molecule with substituent sites
- Fig. 6 shows, schematically, the method according to a preferred embodiment of the present invention.
- Fig. 1 shows, schematically, a chemical compound 10 having a core scaffold 20 and three sites of variation around that scaffold, labelled ⁇ , ⁇ and ⁇ .
- chemicals having more than three sites of variation can be used in the method described herein.
- the actual number of sites to be varied w ill largely depend upon the application envisaged for the chemicals to be generated and on the synthetic route.
- Three examples of scaffolds are shown in Figs. 2a, 2b and 2c, and an example of a hetero scaffold with 2 substituent sites (Si and S 2 ) where variation can occur, formed by the reaction of two monomers, is shown in Fig. 3.
- the multiple arrows shown in Fig. 3 denote that the reaction is carried out over several synthetic steps.
- scaffolds may have numerous substituent group sites. Three such examples are shown in Figs. 4a, 4b and 4c. In most cases, it is unlikely that more than four different sets of monomers would be varied in pharmaceutical applications, except in the case of oligopeptides which contain long lengths of amino acids; the principle, however, is not limited to any specific number of sites and is applicable to compounds synthesised by sequential addition of monomers and hence containing no core scaffold. Such an arrangement is shown in Figure 5, in which the multiple arrows denote that the reaction is carried out over several synthetic steps.
- the first step 100 in a preferred embodiment of the present invention is to identify a group of n compounds or "elements" for each of the candidate substituent group sites on the scaffold, preferably using a cluster analysis.
- the latter may be achieved using the 2D fingerprints approach, discussed by Brown et al. This approach defines strings of 0/1 values indicating the absence/presence of structural fragments within possible groups; such strings can be calculated using commercially available software such as that from Tripos or Daylight.
- combinations of properties and structural fragments are preferred, while for sets showing a limited amount of diversity, properties only are preferred to model diversity.
- a preferred approach here is to use a hierarchical clustering approach, such as Ward's (see the Brown reference, referred to above), coupled with manual or automated selection of substituent group candidates from the clusters identified.
- Other known clustering techniques or selection algorithms may be used.
- a Latin Square is a square array of side n that contains symbols from a set of size n. The symbols are arranged so that every row of the array has each symbol of the set occuring exactly once, and also every column of the array has each symbol of the set occuring exactly once. Thus, the symbols are arranged in such a way that no orthogonal (row or column) contains duplicate symbols.
- a Graeco-Latin Square (used in some embodiments to be described below) is formed when two Latin Squares with sides of dimension j are superimposed on one another in such a way that each of the j 2 combinations of the symbols (taking the order of the superimposition into account) occurs exacth' once in the j 2 cells of the array.
- the two individual Latin Squares are then said to be "orthogonal”. See Montgomery, D.C., Design and Analysis of Experiments. Third Edition, Pub. John Wiley & Sons, New York (1991).
- the PAD may consist of a Graeco- Latin square, as explained above.
- the scaffold has four sites ⁇ , ⁇ , ⁇ and ⁇ . where substituent groups can be added. The first three ( ⁇ , ⁇ and ⁇ ). are labelled as in table 1.
- the fourth site, ⁇ also has five candidates, labelled a to e.
- a Graeco-Latin square of a prime number dimension can always be generated, but solutions can only be derived for certain other dimensions.
- the number of candidates on each site may therefore need to be partially restricted, to ensure all combinations of pairs of substituent group candidates will be present.
- Graeco-Latin Squares for 4 sets of substituents can be extended to more sets of substituents by adding an additional orthogonal Latin Square for each new set of substituents.
- These orthogonal squares are generated in the following general manner.
- the 2 sides of the square remain invariant in all cases as in Table 1 for the first 2 substituents.
- the third substituent is added as in Table 1 i.e. the first row is in order (here, 1 to 5); in the second row. the numbers are shifted one position to the left; in the third row they are shifted again one position to the left and so this continues as one goes down the rows.
- Table 2 shows the square when the fourth substituent is added.
- the orthogonal diagonal has repeat copies of each scaffold. This modification is dictated by the limited number of scaffolds (compared with the number of substituent group candidates) which would normally be incorporated into a single chemical array due to synthetic complexity.
- m" compounds are generated from a total all-combinations array size m x 3.
- dimers may also, on occasion, be desirable to have repeated dimers within the PAD so that, when the compounds are subsequently synthesised and screened, a single error in the screening process will not necessarily invalidate the figures for that dimer pair which was being screened when the error occurred.
- Such an enlarged array can be achieved by using more than 1 Latin Square.
- PAD The flexibility of the PAD allows for different numbers of candidates to be used at each site. This is particularly useful when a more focused, smaller selection of candidates for some of the sites has been possible. For example, with 10 different candidates at site ⁇ (labelled i to x) and 5 different candidates at each of sites ⁇ and ⁇ , the following PAD can be used:
- the next step, 120, in the process of Fig. 6 is to synthesise each of the compounds in the PAD.
- the synthesized compounds are then tested for biological activity at step 130.
- the substituent group activity contributions are calculated on the basis of the actual biological activity for each tested sample.
- b number of compounds containing the substituent group candidate for that site
- o the observed number of biologically active compounds containing the substituent group candidate at that site (or the sum of the activities recorded for compounds containing the substituent group candidate in the range 0 tol , where 1 denotes maximum activity and 0 denotes inactive)
- e the expected number of active compounds that would be associated with the substituent group candidate by chance and is calculated as:
- t total number of biologically active compounds (or sum of activities for quantified activity expressed in the range 0 to 1. where 1 denotes maximum activity and 0 denotes inactive).
- This information is then used, at step 150 of the method of Fig. 6, to provide a prediction of activity' for all of the entries in the entire combinatorial array of compounds. In many circumstances, this may be done simply by summing the calculated substituent group activity contributions for each compound; e.g. for 3 sites of variation, the predicted activity rating CT OTAL may be calculated as:
- C ⁇ is the activity contribution calculated for the substituent group at the ⁇ site
- Cp is the activity contribution calculated for the substituent group at the ⁇ site
- C ⁇ is the activity contribution calculated for the substituent group at the ⁇ site.
- a suitable function may be chosen, according to the application, on the basis either of theoretical considerations or practical considerations. If sufficient data is available, the function might have a number of adjustable parameters that may be automatically selected to provide the best fit to the data. For example, the function might be:
- a, b and c are parameters selected to provide the best fit, overall, between predicted activity ratings and actual measured activity values for the synthesised compounds; an error function may be created which may then be minimised to perfect the fit.
- a skilled man will have no difficulty in deriving other appropriate parameter- based functions that could be fitted on the basis of the data available, for example using a multi-dimensional least squares approach.
- a neural network or a rule induction algorithm could also be used.
- variable function to be fitted assessing to the available data, is a particularly useful approach when the individual substituent group candidates are expected to be either synergistic or antagonistic.
- the data and functions may conveniently be embodied within a spreadsheet- based analysis program, and a specific example of such an approach will now be provided.
- the PAD in this case is of the type shown in table 1 , above, and will have m 2 (i.e. 961) entries.
- the all-combinations array will have m 3 (i.e. 29,791) entries.
- a spreadsheet is created with the following pages (or worksheets): -
- Page 1 consists of the following columns containing information on the n" compounds synthesized: -
- the operator enters a 1 in the activity column for each compound which is active.
- a quantified measure of activity may be used such as % activity in the range 0 to 100.
- the total activity is calculated as the sum of all the activity values and this measure is used as a weight rather than a 0/1 indicator.
- the algorithms remain essentially the same whichever method is used.
- Page 2 consists of the following columns containing information on the entire virtual set of n 3 compounds: -
- ⁇ is multiplied by the sign of the difference between observed and expected.
- substituent group candidates associated with activity have a large positive ⁇ "
- those associated with inactivity have a large negative ⁇ 2 .
- sign (o-e) +1 for substituent group candidates with a higher occurrence in active compounds than expected (i.e. higher than the mean).
- sign (o-e) -1 for substituent group candidates with a lower occurrence in active compounds than expected (i.e. lower than the mean).
- sign (o-e) 0 for substituent group candidates with the expected occurrence of actives (i.e. equal to the mean).
- Graphs are generated to provide a visual display of substituent group activity contributions and measured versus predicted activity for the compounds synthesized.
- the columns in the spreadsheet can be sorted by descending predicted activity rating.
- compounds predicted to be active are clustered at the top of the worksheet and may be readily identified. Those not already synthesized can then be identified and decisions made on which to synthesise. Typically, all compounds predicted to be active, or at least the most likely looking candidates. are synthesised (step 160 of Fig. 6). In deciding which compounds are worthy of synthesis, the operator may take the ⁇ values into consideration.
- these newly-synthesised candidates are then tested for biological activity at 130.
- the array is updated, and the calculations repeated using the new information to update the average constituent group contribution values.
- These new values are then used to recalculate the predicted activity values for those virtual compounds in the all- combinations array that have not yet been synthesised, and the process is repeated.
- the iterative procedure can be expanded still further, if desired, as indicated at step 170. If, during the steps 120 to 140 above, certain substituent group candidates are found to have increased activity, the original cluster analysis outlined in connection with step 100 can be consulted once more. The cluster analysis may indicate a group of substances, not included in the previous all- combinations array, clustered around the substituent group candidates found in that previous array to have increased activity. The PAD can then be reconstructed with different substituent group candidates, using the results of the cluster analysis.
- Activity data for the newly synthesized compounds can be entered into the model and the substituent group activity contributions and predicted activities can be up-dated.
- substituent group site ⁇ consists of 31 candidates labelled A to Z. then AA to
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98946584A EP1034153A1 (en) | 1997-11-24 | 1998-10-08 | Method of designing chemical substances |
AU93586/98A AU9358698A (en) | 1997-11-24 | 1998-10-08 | Method of designing chemical substances |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9724784.5 | 1997-11-24 | ||
GBGB9724784.5A GB9724784D0 (en) | 1997-11-24 | 1997-11-24 | Method of designing chemical substances |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999026901A1 true WO1999026901A1 (en) | 1999-06-03 |
Family
ID=10822540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1998/003017 WO1999026901A1 (en) | 1997-11-24 | 1998-10-08 | Method of designing chemical substances |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1034153A1 (en) |
AU (1) | AU9358698A (en) |
GB (1) | GB9724784D0 (en) |
WO (1) | WO1999026901A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003081510A1 (en) * | 2002-03-26 | 2003-10-02 | Council Of Scientific And Industrial Research | Method and system to build optimal models of 3-dimensional molecular structures |
CN111051876A (en) * | 2017-09-06 | 2020-04-21 | 株式会社半导体能源研究所 | Physical property prediction method and physical property prediction system |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5463564A (en) * | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
WO1996022529A1 (en) * | 1995-01-20 | 1996-07-25 | Arqule, Inc. | A method of generating a plurality of chemical compounds in a spatially arranged array |
-
1997
- 1997-11-24 GB GBGB9724784.5A patent/GB9724784D0/en not_active Ceased
-
1998
- 1998-10-08 EP EP98946584A patent/EP1034153A1/en not_active Withdrawn
- 1998-10-08 AU AU93586/98A patent/AU9358698A/en not_active Abandoned
- 1998-10-08 WO PCT/GB1998/003017 patent/WO1999026901A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5463564A (en) * | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
WO1996022529A1 (en) * | 1995-01-20 | 1996-07-25 | Arqule, Inc. | A method of generating a plurality of chemical compounds in a spatially arranged array |
Non-Patent Citations (4)
Title |
---|
BROWN R D ET AL: "USE OF STRUCTURE - ACTIVITY DATA TO COMPARE STRUCTURE-BASED CLUSTERING METHODS AND DESCRIPTORS FOR USE IN COMPOUND SELECTION", JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, vol. 36, no. 4, 1996, pages 572 - 584, XP002061170 * |
MARTIN E J ET AL: "MEASURING DIVERSITY: EXPERIMENTAL DESIGN OF COMBINATORIAL LIBRARIES FOR DRUG DISCOVERY", JOURNAL OF MEDICINAL CHEMISTRY, vol. 38, 28 April 1995 (1995-04-28), pages 1431 - 1436, XP000611892 * |
SHERIDAN R P ET AL: "USING A GENETIC ALGORITHM TO SUGGEST COMBINATORIAL LIBRARIES", JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, vol. 35, no. 2, 1 March 1995 (1995-03-01), pages 310 - 320, XP000576026 * |
SINGER, BURTON H. ET AL: "Irregular arrays and randomization", PROC. NATL. ACAD. SCI. U. S. A. (1998), 95(4), 1363-1368, XP002096032 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003081510A1 (en) * | 2002-03-26 | 2003-10-02 | Council Of Scientific And Industrial Research | Method and system to build optimal models of 3-dimensional molecular structures |
US7158891B2 (en) | 2002-03-26 | 2007-01-02 | Council Of Scientific & Industrial Research | Method and system to build optimal models of 3-dimensional molecular structures |
CN111051876A (en) * | 2017-09-06 | 2020-04-21 | 株式会社半导体能源研究所 | Physical property prediction method and physical property prediction system |
Also Published As
Publication number | Publication date |
---|---|
GB9724784D0 (en) | 1998-01-21 |
AU9358698A (en) | 1999-06-15 |
EP1034153A1 (en) | 2000-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lommerse et al. | A test of crystal structure prediction of small organic molecules | |
Cawse | Experimental design for combinatorial and high throughput materials development | |
Balcells et al. | tmQM dataset—quantum geometries and properties of 86k transition metal complexes | |
Basak et al. | Topological indices: their nature and mutual relatedness | |
Schäfer et al. | Scaffold Hunter: a comprehensive visual analytics framework for drug discovery | |
Burgess et al. | Combinatorial technologies involving reiterative division/coupling/recombination: statistical considerations | |
Olsson et al. | D-optimal onion designs in statistical molecular design | |
Harper et al. | Design of a compound screening collection for use in high throughput screening | |
Schnur | Design and diversity analysis of large combinatorial libraries using cell-based methods | |
Duca et al. | Estimation of molecular similarity based on 4D-QSAR analysis: formalism and validation | |
Lipkus et al. | Recent changes in the scaffold diversity of organic chemistry as seen in the CAS registry | |
Cundari et al. | Design of a propane ammoxidation catalyst using artificial neural networks and genetic algorithms | |
Mason et al. | Diversity assessment | |
Stanton et al. | Computer-assisted study of the relationship between molecular structure and surface tension of organic compounds | |
AU2002215028A1 (en) | Method of operating a computer system to perform a discrete substructural analysis | |
Grothaus et al. | Automatic layout and visualization of biclusters | |
Umashankar et al. | Drug discovery: An appraisal | |
Gorse et al. | Functional diversity of compound libraries | |
Schuffenhauer et al. | Clustering and rule-based classifications of chemical structures evaluated in the biological activity space | |
US6253168B1 (en) | Generation of virtual combinatorial libraries of compounds | |
Senese et al. | A simple clustering technique to improve QSAR model selection and predictivity: Application to a receptor independent 4D-QSAR analysis of cyclic urea derived inhibitors of HIV-1 protease | |
EP1034153A1 (en) | Method of designing chemical substances | |
Martin | Lattice enumeration for inverse molecular design using the signature descriptor | |
Wawer et al. | Elucidation of structure− activity relationship pathways in biological screening data | |
Cerruela García et al. | Analysis and study of molecule data sets using snowflake diagrams of weighted maximum common subgraph trees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998946584 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09554828 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998946584 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998946584 Country of ref document: EP |